Global Health recommends 'Linakapafir' injection to prevent AIDS

The World Health Organization on Monday recommended that the use of the “Linacapaver” medicine produced by the company “Gilliad Sciences” be produced twice a year in injection to prevent HIV infection. This recommendation, issued at the International AIDS conference held in Rwanda, is almost a month after the approval of the US Supervisory Authority for the property, giving patients new hope to prevent the virus from moving. The property, after receipt of twice a year, provides a long alternative to the grains taken daily by mouth and other short -acting options, reformulating the methods of controlling the disease, especially among those who have trouble taking medication daily or to stigmatize it due to diseases or health care. “While acquiring a vaccine for HIV is still a prolonged, lina capter is the second best option,” said World Health Organization Director General Tedros Adhanum Jibrisus. The recommendations of the World Health Organization come at a critical time, as efforts to prevent the virus from stagnating with 1.3 million new injuries in 2024, while the financing and stigma problems that surround the disease continue. The most vulnerable categories of AIDS and the risk of infection increases in certain population groups, such as workers and sex workers, gay, transgender, drug users by injection, prison guests, children and adolescents. The organization recommended that an approach dealing with public health on dealing with the virus using quick tests would remove a major obstacle to get appropriate care to eliminate complicated and expensive procedures. The effectiveness of “Linakapafir”, a medicine category known as the virus’s protein inhibitors, was about 100% in the prevention of HIV in important experiences performed last year.